ampligen
Generic: rintatolimod
ampligen: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| AIM ImmunoTech Inc. (AIM) | Phase 2 |
Get deeper analysis on ampligen
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis